**Author details**

Ricardo Rodrigues Figueiredo1,2\*, Andréia Aparecida de Azevedo2,3 and Norma de Oliveira Penido<sup>3</sup>

\*Address all correspondence to: rfigueiredo@otosul.com.br

1 Faculdade de Medicina de Valença, Valença, RJ, Brazil

2 Tinnitus Research Initiative Pharmagroup

3 Universidade Federal de São Paulo, SP, Brazil

## **References**


[15] Ferendiuk E, Zajdel K, Pihut M. Incidence of otolaryngological symptoms in patients with temporomandibular joint dysfunctions. BioMed Research International. 2014;**2014**:824684.DOI:10.1155/2014/824684.Epub 2014 Jun 24.

**References**

156 Up to Date on Meniere's Disease

s00415‐015‐7930‐1

DOI: 10.3233/VES‐150549

DOI: 10.1111/nyas.12699

America. 2003;**36**(2):239‐248

Otorrinolaringológica Española. 2007;**58**(9):426‐433

Surgery. 2014;**151**(2):1‐40. DOI: 10.1177/0194599814545325

trol. Brazilian Journal of Otorhinolaryngology. 2012;**78**(6):21‐26

amjmed.2010.02.015

2005;**48**(5):49‐70

[1] Atkinson M. Ménière's original papers reprinted with an English translation with com‐

[2] Gürkov R, Pyyko I, Kentala F. What is Ménière's disease? A contemporary re‐evalua‐ tion of endolymphatic hydrops. Journal of Neurology. 2016;**263**(1):71‐81. DOI: 10.1007/

[3] Havia M, Kentala E, Pyykö I. Prevalence of MD in general population of Southern

[4] Lopez‐Escamez JA, Carey J, Chung W, Goebel JA, Magnusson M, Mandala M et al. Diagnostic criteria for Menière's disease. Journal of Vestibular Research. 2015;**25**:1‐7.

[5] Pyykö I, Nakashima T, Yoshida T, Zou J, Naganawa S. Ménière's disease: A reappraisal supported by a variable latency of symptoms and the MRI visualization of endolymphatic hydrops. British Medical Journal Open. 2013;**3**(2). DOI: 10.1136/bmjopen‐2012‐001555

[6] Ishiyama G, Lopez IA, Sepahdari AR, Ishiyama A. Meniere's disease: Histopatology, cytochemistry and imaging. Annals of the NewYork Academy of Sciences. 2015;**22**:1‐9.

[7] Eckhard A, Gleiser C, Arnold H, Rask‐Andersen H, Kumagami H, Müller M et al. Water channel proteins in the inner ear and their link to hearing impairment and deafness. Molecular Aspects of Medicine. 2012;**33**(5‐6):612‐37. DOI: 10.1016/j.mam.2012.06.004

[8] Heller AJ. Classification and epidemiology of tinnitus. Otolaryngologic Clinics of North

[9] Shargorodsky J, Curhan GC, Farwell WR. Prevalence and characteristics of tinnitus among US adults. The American Journal of Medicine. 2010;**123**(8):711‐718. DOI: 10.1016/j.

[10] Herraiz C, Aparicio JM. Diagnostic clues in pulsatile tinnitus (somatosounds). Acta

[11] Langguth B, Kreuzer PM, Kleinjung T, De Ridder D. Tinnitus: Causes and clinical man‐ agement. The Lancet Neurology. 2013;**12**(9):920‐930. DOI: 10.1016/S1474‐4422(13)70160‐1

[12] Tunkel DE, Bauer CA, Sun GH, Rosenfeld RM, Chandrasekhar SS, Cunningham ER Jr et al. Clinical practice guideline: Tinnitus. Journal of Otolaryngology Head and Neck

[13] Henry JA, Dennis KC, Schechter MA. General review of tinnitus: prevalence, mecha‐ nisms, effects and management. Journal of Speech Language and Hearing Research.

[14] Rocha CB, Sanchez TG. Efficacy of myofascial trigger point deactivation for tinnitus con‐

mentaries and biographical sketch. Acta Otolaryngolica. 1961;**162**:1‐78

Finland. Otolaryngology Head and Neck Surgery. 2005;**133**(5):762‐768

